microbiome

Candida Overgrowth & SIBO Explained: Symptoms, Root Causes, and Healing ROAdMAP

antifungal herbs, bloating, brain fog, candida, candida cleanse, candida overgrowth, fungal, immune system, microbiome, SIBO, SIBO and candida, SIFO, sugar craving, women’s gut health, yeast overgrowth

If you've ever felt like your gut is running the show, and not in a good way, you're not alone.

Perhaps you wake up with a flat stomach, but by dinnertime, you look five months pregnant. Or maybe you feel exhausted no matter how much you sleep, wrestle with relentless sugar cravings, or experience mood swings that make you feel like you're on a hormonal rollercoaster. You've tried eating "clean," taking probiotics and cutting out gluten, yet the bloating, fatigue, and brain fog just won't budge.

Many people are unknowingly dealing with a tangled web of gut dysfunction. And at the center of that web? Often, it's a hidden combination of Candida overgrowth & SIBO (Small Intestinal Bacterial Overgrowth) that quietly wreaks havoc behind the scenes.

These conditions aren't just buzzwords tossed around in wellness circles. They're very real, very disruptive, and can become chronic and life-altering.

But here's the good news: understanding the connection between them is the first step toward untangling your symptoms and healing your gut from the inside out.

What is SIBO?

SIBO, or Small Intestinal Bacterial Overgrowth, occurs when bacteria that normally reside in the large intestine begin to colonize the small intestine. In this space, they don't belong in large numbers. It can also mean an imbalance in the type of bacteria that reside in the small intestine, since it is not a sterile environment. These bacteria produce hydrogen or hydrogen sulfide gas.

Besides bacteria, another organism could also cause trouble, namely, methanogens that produce methane gas. In this case, we talk about Intestinal Methanogen Overgrowth (or shortly IMO).

This overgrowth disrupts digestion and nutrient absorption, triggers inflammation, and ferments food before your body can properly break it down, leading to a cascade of frustrating symptoms. (1)

Common symptoms of SIBO

Although the presentation varies, the hallmark signs of SIBO include:

Bloating (especially post-meal)
Excess gas (flatulence or belching)
Diarrhea, constipation, or an alternating pattern
Abdominal pain or discomfort
Unintended weight loss or gain
Fat-soluble vitamin deficiencies (A, D, E) and mineral deficiencies (esp. iron)
Brain fog and fatigue
Skin issues (eczema, acne, rosacea)
Histamine intolerance and other food sensitivities

One study found that up to 80% of people diagnosed with IBS actually test positive for SIBO through breath testing, suggesting a huge portion of "IBS" cases could actually be SIBO in disguise. (2)

How is SIBO diagnosed?

Diagnosing SIBO isn't always straightforward, but the gold standard is the lactulose or glucose breath test. This test measures the levels of hydrogen and methane gas (or, in some cases, hydrogen sulfide gas) produced by bacterial (or other organisms) fermentation in the small intestine after consuming a sugar solution. (3)

What causes SIBO?

SIBO doesn't appear out of nowhere. It's typically the result of an underlying condition that disrupts normal gut motility, digestive juice levels, or immune defense.

Here are some of the most common root causes (4)(5):

Low stomach acid (Hypochlorhydria): Often caused by aging, chronic stress, Helicobacter pylori infection, or the use of stomach acid-suppressing medications (such as proton pump inhibitors, H2-receptor antagonists, or antacids), this condition allows bacteria to survive and enter the small intestine.
Poor gut motility: Conditions like hypothyroidism, diabetes, and post-infectious IBS can slow the Migrating Motor Complex (MMC), which is the cleansing wave that clears bacteria and remaining food particles from the small intestine toward the colon.
Scar tissue or adhesions: These can result from surgeries, C-sections, or endometriosis and physically impair intestinal movement.
Food poisoning can trigger autoimmune damage to nerves that regulate intestinal motility, a condition known as post-infectious IBS.
Regular antibiotic use: Wipes out beneficial bacteria, allowing opportunistic microbes to dominate.
Ileocecal valve dysfunction: This "gate" between the small and large intestine can malfunction, allowing bacterial backflow.

Identifying the root causes is crucial. Otherwise, SIBO is likely to return even after treatment.

What is Candida?

Candida is a type of yeast—a fungus, to be precise—that naturally lives in small amounts throughout your digestive tract, mouth, skin, and vaginal area.

In healthy individuals, this yeast is kept in check by the immune system and beneficial gut bacteria. However, when the balance is disrupted, Candida can grow out of control, leading to a condition known as Candida overgrowth.

This isn't just about an annoying yeast infection. When Candida takes over the system, especially in the gut, it can contribute to a range of symptoms, including bloating, sugar cravings, brain fog, fatigue, and recurring infections.

What I often find is that Candida overgrowth & SIBO exist in tandem, "feeding off" the same triggers, such as antibiotic use, sugar-heavy diets, stress, and gut dysbiosis, creating a feedback loop that's incredibly difficult to break without a holistic strategy. (6)

Symptoms of Candida overgrowth

Candida is a shapeshifter, literally. It can switch between a benign yeast form and a more aggressive fungal form (hyphal), allowing it to burrow into tissue and produce biofilms that protect it from your immune system and medications. This ability is what makes systemic Candida so problematic.

Common signs of Candida overgrowth (7) include:

Bloating, gas, and indigestion
Strong sugar and carb cravings
Fatigue and brain fog
White coating on the tongue (oral thrush)
Recurrent vaginal or urinary tract infections
Skin and nail fungal infections (athlete's foot, toenail fungus)
Mood swings, anxiety, and irritability
Joint pain and muscle aches
Chronic sinus problems

According to a study published in Frontiers in Microbiology, Candida can modulate host immunity, contribute to inflammation, and have been linked to both gastrointestinal and systemic conditions, especially when present in excessive amounts. (8)

Notably, not everyone will experience all these symptoms. Often, just a few persistent signs, especially when traditional treatments are unsuccessful, can indicate underlying yeast overgrowth.

Why does Candida overgrow?

The gut is an ecosystem. When something disrupts the balance, such as the use of antibiotics or a high-sugar diet, Candida can seize the opportunity to flourish. (9)

Here are some of the most common culprits:

Frequent or prolonged antibiotic use: These drugs kill off beneficial bacteria that normally keep Candida in check.
Oral contraceptives: Hormonal birth control has been shown to alter gut flora and encourage yeast growth.
Corticosteroids: These suppress immune function and can promote fungal infections.
High-sugar and high-carb diet: Candida feeds on sugar, and a carb-heavy diet fuels its overgrowth.
Chronic stress: Stress impacts cortisol levels and immune surveillance, allowing opportunistic microbes like Candida to thrive.
Heavy metal toxicity and mold exposure: These environmental toxins can impair immunity and gut resilience.
Hormonal imbalances: Estrogen dominance has been associated with higher rates of yeast infections and intestinal overgrowth.

Research also suggests that individuals with weakened immunity, whether due to chronic illness, autoimmunity, or untreated SIBO, are more susceptible to Candida infections. (10)

Normally, Candida lives harmlessly as part of your gut flora, but your gut immune system plays a big role in keeping it under control. Over 70% of your immune cells are found in the gut lining, where they help distinguish between friendly microbes and troublemakers like Candida in its aggressive fungal form. When the immune system is compromised, Candida can switch from a harmless yeast to an invasive fungus, penetrating tissues, releasing toxins, and hijacking the metabolism and mood. (11)

How is Candida diagnosed?

Candida overgrowth is notoriously difficult to diagnose using conventional methods. (12)

Functional testing offers more accurate clues:

Urine Organic Acids Test (OAT): This test can detect byproducts of Candida metabolism, like arabinose and tartaric acid. It's one of the most sensitive tools available, although it still cannot identify the location of the overgrowth.

OAT test showing elevated fungi levels — OAT test showing elevated arabinose and tartaric acid levels, indicating fungal overgrowth

Comprehensive Stool Analysis: This test can reveal fungal overgrowth in the colon, though it may miss overgrowth localized in the small intestine or systemically.

GI MAP stool test showing elevated Candida spp — The GI MAP stool test shows elevated Candida spp. levels

Blood Antibody Tests (IgG, IgA, IgM): These can suggest current or past Candida infections, but results must be interpreted cautiously.
Swab cultures: In case of oral or vaginal infections, swabs could be taken from the affected area and cultured or analyzed.
Clinical history and symptom tracking: In practice, this is often the most reliable indicator, especially when lab tests are inconclusive.

SIBO vs. Candida overgrowth

At this stage, it's essential to pause and connect the dots. Many of the symptoms of Candida overlap with those of SIBO. So, how do we tell them apart? And why do they so often show up together?

When it comes to gut dysfunction, Candida overgrowth & SIBO share a frustrating number of overlapping symptoms.

But beneath the surface, these are two very different microbes—bacterial and fungal—and each requires a distinct treatment approach. Misidentifying one for the other (or worse, missing one entirely) is a common reason why so many people stay stuck in the cycle of temporary relief and recurring flare-ups.

If you've treated SIBO and your bloating still hasn't budged, or you've done "Candida cleanses" with no lasting relief, it's time to consider the possibility of both conditions lurking beneath the surface.

Overlapping symptoms

Here's a snapshot of the common symptoms shared by Candida overgrowth & SIBO:

Bloating and distension (especially after meals)
Food intolerances (gluten, dairy, histamines, fermented foods)
Fatigue, brain fog, irritability
Constipation, diarrhea, or alternating bowel movements
Sugar cravings and mood swings
Skin issues (eczema, rashes, acne)
Difficulty losing weight
Bad breath, coated tongue

These symptoms are so nonspecific that many people are misdiagnosed with IBS, anxiety, or even hypochondria before a proper workup is done.

But here's what sets them apart underneath the hood:

SIBO

Cause: Overgrowth of bacteria in the small intestine. (but this is also happening due to hidden underlying causes).

Gases produced: Hydrogen, methane, or hydrogen sulfide. Each is linked to distinct symptom patterns (e.g., methane is commonly associated with constipation).

Main trigger foods: High-FODMAP carbohydrates like onions, garlic, apples, lentils, and wheat.

Test of choice: Lactulose or glucose breath test.

SIBO often causes rapid bloating, which can occur within 30–60 minutes of eating. It also creates a lot of gas, either via burping, flatulence, or both, due to fermenting carbohydrates before they're properly digested.

Candida overgrowth

Cause: Overgrowth of Candida albicans (a fungus, but it could be other species) often happens after taking antibiotics or other medications, going through a stressful period, or consuming a high amount of sugar or processed foods.

Byproducts: Acetaldehyde, ammonia, ethanol, chemicals that can damage tissues and trigger systemic symptoms.

Main trigger foods: Sugar, alcohol, refined carbs, yeast-containing foods.

Test of choice: Organic Acids Test, stool analysis, or antibody blood work.

Candida is sneaky. It may not cause much gas but instead shows up with sugar cravings, recurring yeast infections, oral thrush, skin rashes, and even mood symptoms like anxiety and depression. Its byproducts—especially acetaldehyde—have been shown to interfere with neurotransmitters like dopamine and serotonin, linking Candida to mood disorders. (13)

How SIBO and Candida feed each other

Here's the kicker: it's incredibly common for people to have both Candida overgrowth & SIBO at the same time.

Here's why:

Candida weakens the gut barrier, creating microscopic leaks in your intestinal lining (a.k.a. "leaky gut"), which makes it easier for bacteria to migrate from the large intestine to the small intestine, setting the stage for SIBO. (14)
On the flip side, SIBO disrupts immune surveillance and digestive function, reducing the gut's ability to keep Candida in check. (15)
Both can result from chronic antibiotic use, poor gut motility, low stomach acid, and dysbiosis. So it's not just that they coexist; it's that they amplify each other.

What happens when you treat one but not the other?

Many practitioners (myself included) have seen clients who've been treated for SIBO multiple times or treated for H. Pylori infection with antibiotics, only to end up feeling worse. Why? Because those same antibiotics wiped out bacterial overgrowth but allowed Candida to surge in its place.

This is a classic case of what we call "microbial whack-a-mole." Knock down one overgrowth without restoring balance, and another opportunist takes its place.

That's why a personalized, whole-systems approach is essential. When you understand how Candida overgrowth & SIBO interact, you can stop the guessing game and start a true healing journey.

SIFO vs. Candida overgrowth and their link to SIBO

Just when you thought you'd mapped out all the key players in your gut health story, there's one more under-the-radar disruptor that often flies beneath the diagnostic radar: SIFO, or Small Intestinal Fungal Overgrowth.

What is SIFO?

SIFO, or Small Intestinal Fungal Overgrowth, is a condition where fungi (most often Candida) overgrow, specifically in the small intestine. The same space where SIBO occurs, but this time, it's a fungal, not bacterial, issue.

Unlike colon-based Candida overgrowth, SIFO is localized, affecting digestion at its most vulnerable point. While it's often overlooked, SIFO can mimic—or even coexist with—SIBO, leading to misdiagnosis and incomplete treatment.

What makes SIFO particularly tricky is that its symptoms often mimic SIBO, such as bloating, pain after meals, and food sensitivities, but it doesn't always show up on traditional tests.

In one study published in 2014, researchers found that over 25% of patients with unexplained gastrointestinal symptoms actually had SIFO, many of whom tested negative for SIBO. That's a lot of people flying under the radar. (16)

What's the difference between SIFO vs. Candida overgrowth?

Difference between SIFO vs Candida overgrowth

Candida overgrowth often affects the entire body (skin, mouth, genitals, sinuses), while SIFO's effects are mostly digestive.

But here's where it gets tricky: many people with SIFO don't show external yeast symptoms, so unless a practitioner is trained to look deeper, it's often missed.

How SIFO and SIBO work together (or against you)

The small intestine isn't sterile, but it is meant to maintain a delicate balance of microbes, with far fewer and different types than those found in the large intestine. It's designed for nutrient absorption, not fermentation. (18)

But in cases of chronic gut dysfunction, whether through slowed gut motility, low stomach acid, or microbial migration, Candida overgrowth & SIBO can coexist, creating a storm of inflammation, immune reactivity, and digestive misery.

Let's break down how they feed each other:

Reduced gut motility (think slow intestinal transit): Allows both bacteria and fungi to stagnate and multiply. (15)
Antibiotics wipe out bacteria, but not yeast: Treating SIBO without antifungals can lead to SIFO, especially in women who are more likely to be yeast-prone. (15)
Candida damages the gut lining: This makes it easier for SIBO to recur because your gut's protective barriers are compromised. (14)
Compromised immunity: Chronic inflammation, stress, mold exposure, and poor sleep all impair your immune response, making it harder to fight both bacterial and fungal invaders. (15)

One clinical paper in FEMS Microbiology Reviews explains how Candida albicans form protective biofilms that make them resistant to antifungals and how they interact with bacteria in mixed-species communities to shield each other from treatment. (19) This may explain why many people feel better for a while…until symptoms return with a vengeance.

Are you dealing with SIBO, SIFO, or both?

Here are a few clues that SIFO may be in the mix, especially after treating SIBO:

You experience increased bloating, fatigue, and sugar cravings after antibiotics.
You've had recurrent vaginal yeast infections or thrush.
You feel "drunk" or foggy-headed after eating sugar or carbs.
Your breath test was negative, but your gut symptoms persist.
You've taken PPIs, steroids, or the birth control pill long-term.

If any of these resonate, it's time to expand the scope of treatment. Ignoring fungal overgrowth while focusing only on bacteria is like trying to fix one leak in a sinking boat while ignoring the hole in the floor.

Natural healing options for Candida overgrowth & SIBO

When dealing with Candida overgrowth & SIBO, the path to healing can feel overwhelming, like navigating a maze blindfolded. But with the right roadmap, testing, and support, you can break the cycle of bloat, brain fog, and burnout.

Let's explore what holistic and functional strategies actually work for SIBO and Candida and when they coexist.

A. Diet: the foundation of gut healing

Food can be your best medicine or your biggest trigger. Tailoring your diet is the first step in calming inflammation and reducing overgrowth.

For SIBO:

Low-FODMAP diet: Temporarily limits fermentable carbs like garlic, onions, apples, legumes, and wheat. These ferment in the small intestine and can feed bacteria. Studies showed a significant reduction in IBS symptoms using a low-FODMAP diet in the short term. (20) Despite limited direct research on the effectiveness of the low-FODMAP diet specifically for SIBO, it is commonly recommended due to the overlapping symptoms with IBS to control the symptoms and to reduce fermentation in the small intestine. The diet is aimed at reducing symptoms, but it will not resolve SIBO on its own.
SIBO Bi-Phasic Diet (created by Dr. Nirala Jacobi): Introduces foods in phases, starting with low fermentation options and then reintroducing slowly.
Avoid alcohol, gluten, and sugar, which may impair gut motility and feed "bad" bacteria.

For more information on which foods to avoid and how to find suitable alternatives, check out my previous blog post.

For Candida:

Low-sugar, gluten-free, anti-yeast diet: Cut added sugars, fruit juices, alcohol, and refined grains (esp. wheat). (21)
Focus on: Non-starchy vegetables, lean proteins, healthy fats (avocado, coconut, olive oil), and low-sugar fruits like berries and green apples.
Include antifungal foods: Garlic, ginger, lemongrass, olive oil, apple cider vinegar, cinnamon, coconut oil (contains caprylic acid), thyme, and oregano. (22)

For both:

Gluten-free, low-starch, nutrient-dense: Base your meals on leafy greens, cruciferous veggies (as much as tolerated), pasture-raised proteins, and healthy fats.
Bone broth and collagen for gut lining support.
Stay hydrated with electrolytes (especially during detox phases).

Tip: Don't starve yourself to kill bugs; support your body with nourishing, whole foods that promote healing, not just restriction.

B. Supplements: antimicrobials, antifungals, and biofilm busters

Choosing the right supplements can speed healing and reduce symptoms, but they must be used strategically.

For SIBO:

Herbal antimicrobials:

- Allicin (garlic extract) – Effective for methanogen overgrowth (for IMO – Intestinal Methanogen Overgrowth) (23) and has antimicrobial effects against Pseudomonas, Streptococcus, Staphylococcus (24), and pathogenic strains of Escherichia coli (25).
- Berberine (26), Neem (27), Oregano Oil (28), and Thyme (29) – Broad-spectrum antimicrobials that rival antibiotics in some studies.

Biofilm disruptors: are agents designed to break down the protective matrix of microbial biofilms, making bacteria more susceptible to antibiotics and immune responses. NAC, Interfase Plus, or enzymes like serrapeptase can break the protective layers that microbes form. (30)

Prokinetics (to support gut motility): Ginger root, Iberogast®, or low-dose erythromycin to stimulate the Migrating Motor Complex.

For Candida:

Antifungal agents:

- Caprylic acid - A medium-chain fatty acid from coconut oil, proven to disrupt Candida cell membranes and inhibit biofilm formation. (31)
- Oregano oil – High in antifungal compounds like carvacrol and thymol. (32)
- Garlic extract (allicin) – is also effective against Candida albicans. (33)
- Curcumin, Cinnamaldehyde, Eugenol, and Thymol compounds not only inhibit Candida growth but also disrupt biofilm formation, enhancing their antifungal efficacy. (34)
- Saccharomyces boulardii – A beneficial yeast that inhibits the translocation of C. albicans from the gut to other organs, lowers intestinal colonization and reduces inflammation. (35)

Binders: are substances that can adsorb and help eliminate toxins. Activated charcoal or bentonite clay (under practitioner guidance) can absorb fungal die-off toxins like acetaldehyde. These are typically taken at least 2 hours away from other medications, supplements, and foods to avoid interfering with absorption.

For both:

Choose a few herbs that may be efficient for both. A comprehensive stool test can also help reveal the overgrowth of certain bacterial and fungal species in the intestines, which may help tailor the right treatment approach.
Liver support: Milk thistle, dandelion root, and B-complex to support detox pathways during microbial die-off.
GI support: L-glutamine, aloe vera, deglycyrrhizinated licorice (DGL), and marshmallow root to soothe and rebuild the gut lining. (Be careful if you have an active SIBO, as some of these may worsen the symptoms.)

Don't overlook your immune system. Healing from Candida overgrowth & SIBO isn't just about killing off overgrowths. It's about restoring immune tolerance and regulation. The gut and immune system are in constant dialogue. If that communication breaks down, Candida can keep coming back.

You can support gut immunity with:

Nutrients like vitamin D, zinc, and glutathione
Anti-inflammatory foods like turmeric, omega-3s (fatty fish), and polyphenols (berries, green tea)
Gentle immune modulators like reishi mushroom or beta-glucans.

C. Medications: when natural isn't enough

In stubborn or severe cases, pharmaceuticals may be needed in tandem with lifestyle changes.

For SIBO:

Rifaximin (Xifaxan®) – Non-absorbable antibiotic targeting hydrogen-dominant SIBO.
Rifaximin + Neomycin – For methanogen overgrowth (IMO) (constipation-type). (36)

For Candida:

Nystatin – Stays in the gut; often used for intestinal yeast.
Fluconazole (Diflucan®) – Systemic antifungal; can be effective for deep infections.

Prescription is usually short-term and paired with antifungal herbs, binders, and liver support. (37)

Important: Pharmaceuticals kill microbes but don't rebuild the terrain. They must be followed with healing-focused nutrition and supplementation.

D. Lifestyle & functional strategies

Your nervous system, sleep, and stress response all influence gut health. Healing is more than protocols. It's about creating a body environment where microbes can't thrive.

Vagus nerve stimulation: Humming, gargling, cold exposure, and meditation improve gut motility and immune signaling.
Gentle detox practices: Sweat through the sauna or gentle movement, dry brushing, castor oil packs, and an Epsom salt bath to release toxins.
Meal hygiene: Chew food thoroughly, eat in a parasympathetic (restful) state, and space meals by 3–4 hours to activate MMC (your gut motility).
Sleep: Aim for 7–9 hours; poor sleep impairs microbial balance and immune resilience.

E. Probiotics and prebiotics

Introducing probiotics and prebiotics at the wrong time can worsen symptoms, especially with active SIBO or SIFO.

For Candida:

Saccharomyces boulardii – Antifungal yeast that boosts immune defense. (35)

Lactobacillus rhamnosus GG (LGG) and Lactobacillus acidophilus have been shown to help restore balance. LGG can significantly reduce biofilm formation by Candida albicans and Candida tropicalis. (38)(39) L. acidophilus also shows antifungal effects against various Candida species, especially at higher concentrations, by inhibiting the growth and biofilm formation of most Candida spp. (40)

Several other probiotic strains have demonstrated effectiveness against Candida overgrowth. One study found that giving a multispecies probiotic (containing lyophilized Lactobacillus rhamnosus HS111, Lactobacillus acidophilus HS101, and Bifidobacterium bifidum) was effective in reducing the colonization of the oral cavity with Candida. (41)

For SIBO:

Saccharomyces boulardii - Supports SIBO antibiotic therapy. A clinical trial showed that adding S. boulardii to antibiotic treatment, like metronidazole, improved SIBO eradication rates compared to antibiotics alone. (42)

In another study, in patients with decompensated cirrhosis, a 3-month course of S. boulardii eliminated SIBO in 80% of cases, compared to 23.1% in a placebo group. (43)

Spore-based probiotics (e.g., Bacillus coagulans) – A well-studied soil-based probiotic that can survive stomach acid and doesn't ferment in the small intestine.

In a clinical trial involving 30 individuals with chronic abdominal pain or diarrhea and a positive hydrogen breath test (HBT) for SIBO, B. coagulans Unique IS-2 was found to be effective. After three weeks of antibiotic therapy, participants were given either B. coagulans Unique IS-2 or a placebo for 15 days alongside maintenance antibiotics. After six months, the probiotic group showed significant improvements:

Gastrointestinal symptoms like belching, flatulence, and diarrhea significantly improved.
Abdominal pain disappeared completely.
93% of individuals in the probiotic group had negative HBTs, compared to 67% in the placebo group. (44)

Are you interested in which probiotics could work for SIBO? Read more in my other blog post.

Final thoughts on healing from Candida overgrowth & SIBO

Healing from Candida overgrowth & SIBO isn't a one-size-fits-all journey. It's a layered, strategic process that involves:

Reducing microbial load (without destroying your gut ecosystem)
Rebuilding the gut lining and supporting immune strength
Rebalancing the gut microbiome and lifestyle to support long-term health

And most importantly? Listening to your body and pacing yourself.

If you've made it this far, you already know that Candida overgrowth & SIBO aren't just isolated conditions; they're interwoven, complex, and deeply connected to how you feel every single day.

That stubborn bloating that won't go away, the brain fog that clouds your thoughts, the relentless cravings, the recurring yeast infections, the fatigue you can't shake, it's not "just stress," and it's not all in your head. It's your gut speaking up. Loudly.

And now, you have the clarity to start answering back.

Let's recap what you've learned:

SIBO is an overgrowth of bacteria in the small intestine, often caused by gut motility issues, low digestive juices, toxins, and structural issues.
Candida overgrowth is a fungal imbalance driven by a high-sugar diet, antibiotics, stress, and weakened immunity.
The two conditions often occur together, forming a destructive feedback loop that keeps you feeling unwell.
SIFO is a hidden condition that mimics SIBO but is fungal in nature, often undiagnosed and undertreated.
Healing requires a layered strategy: antimicrobials and antifungals, but also rebuilding, restoring, and rebalancing the entire gut ecosystem.

And most importantly, healing is possible.

Your body isn't broken. It's simply out of balance, and now that you know the "why," you can begin addressing the "how" with precision and compassion.

Ready to end the guesswork?

If you've tried treating SIBO or Candida but still don't feel well, it's not your fault. What you need is a plan that:

Looks at the whole picture, not just the symptoms
Uses functional testing to identify the imbalances
Applies targeted nutrition, supplements, and lifestyle changes
Offers support and accountability from someone who gets it

Book a free SIBO & Gut Assessment Call today and get a customized roadmap based on your unique symptoms, history, and goals.

Because you deserve to feel like yourself again, not just symptom-free, but fully alive.

Disclaimer:

The information provided on this site is for educational purposes only, is not intended as medical advice, and does not claim to diagnose, heal, treat, or cure any conditions Always consult with a healthcare professional before starting any dietary regimen, supplement, or lifestyle changes, especially if you have underlying health conditions or are taking medication.

References

Dukowicz, A. C., Lacy, B. E., & Levine, G. M. (2007). Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterology & hepatology, 3(2), 112–122.
Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut and Liver 2017;11:196-208. https://doi.org/10.5009/gnl16126
Khoshini, R., Dai, SC., Lezcano, S. et al.A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth. Dig Dis Sci 53, 1443–1454 (2008). https://doi.org/10.1007/s10620-007-0065-1
Cho, Y. K., Lee, J., & Paik, C. N. (2023). Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children. Clinical and experimental pediatrics, 66(9), 377–383. https://doi.org/10.3345/cep.2022.00969
Sharabi, E., Rezaie, A. Small Intestinal Bacterial Overgrowth. Curr Infect Dis Rep26, 227–233 (2024). https://doi.org/10.1007/s11908-024-00847-7
Kumamoto, C. A., Gresnigt, M. S., & Hube, B. (2020). The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Current opinion in microbiology, 56, 7–15. https://doi.org/10.1016/j.mib.2020.05.006
R AN, Rafiq NB. Candidiasis. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560624/
Zhou, Y., Cheng, L., Lei, Y. L., Ren, B., & Zhou, X. (2021). The interactions between Candida albicans and mucosal immunity. Frontiers in Microbiology, 12, 652725. https://doi.org/10.3389/fmicb.2021.652725
Jawhara S. (2022). How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation. Microorganisms, 10(5), 1014. https://doi.org/10.3390/microorganisms10051014
Thomas-Rüddel, D. O., Schlattmann, P., Pletz, M., Kurzai, O., & Bloos, F. (2022). Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis. Chest, 161(2), 345–355. https://doi.org/10.1016/j.chest.2021.08.081
Kumamoto, C. A., Gresnigt, M. S., & Hube, B. (2020). The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Current opinion in microbiology, 56, 7–15. https://doi.org/10.1016/j.mib.2020.05.006
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM, Cornely, Oliver A et al.The Lancet Infectious Diseases, Volume 25, Issue 5, e280 - e293. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00749-7/fulltext
Day, A. W., Perez-Lozada, J., DiLeo, A., Blandino, K., Maguire, J., & Kumamoto, C. A. (2025). Candida albicansColonization Modulates Murine Ethanol Consumption and Behavioral Responses Through Elevation of Serum Prostaglandin E₂ and Impact on the Striatal Dopamine System. bioRxiv : the preprint server for biology, 2025.02.25.640044. https://doi.org/10.1101/2025.02.25.640044
Peng, Z., & Tang, J. (2022). Intestinal infection of Candida albicans: Preventing the formation of biofilm by albicans and protecting the intestinal epithelial barrier. Frontiers in Microbiology, 12, 783010. https://doi.org/10.3389/fmicb.2021.783010
Soliman, N., Kruithoff, C., San Valentin, E. M., Gamal, A., McCormick, T. S., & Ghannoum, M. (2025). Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives. Nutrients, 17(8), 1365. https://doi.org/10.3390/nu17081365
Erdogan, A., & Rao, S. S. (2015). Small intestinal fungal overgrowth. Current gastroenterology reports, 17(4), 16. https://doi.org/10.1007/s11894-015-0436-2
Karunaratne, T. B., Sharma, A., & Rao, S. S. C. (2020). Small-bowel aspiration during upper esophagogastroduodenoscopy: Rao technique. VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy, 6(4), 152–154. https://doi.org/10.1016/j.vgie.2020.11.008
Kastl, A. J., Jr, Terry, N. A., Wu, G. D., & Albenberg, L. G. (2020). The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cellular and molecular gastroenterology and hepatology, 9(1), 33–45. https://doi.org/10.1016/j.jcmgh.2019.07.006
Justin Massey, Robert Zarnowski, David Andes, Role of the extracellular matrix in Candidabiofilm antifungal resistance, FEMS Microbiology Reviews, Volume 47, Issue 6, November 2023, fuad059, https://doi.org/10.1093/femsre/fuad059
Whelan, K., & Staudacher, H. (2022). Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses. Current opinion in clinical nutrition and metabolic care, 25(5), 341–347. https://doi.org/10.1097/MCO.0000000000000854
Jeziorek, M., Frej-Mądrzak, M., & Choroszy-Król, I. (2019). The influence of diet on gastrointestinal Candida spp. colonization and the susceptibility of Candida spp. to antifungal drugs. Roczniki Panstwowego Zakladu Higieny, 70(2), 195–200. https://doi.org/10.32394/rpzh.2019.0070
Jawhara S. (2023). Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection. Microorganisms, 11(6), 1556. https://doi.org/10.3390/microorganisms11061556
Ma, T., Chen, D., Tu, Y., Zhang, N., Si, B., Deng, K., & Diao, Q. (2016). Effect of supplementation of allicin on methanogenesis and ruminal microbial flora in Dorper crossbred ewes. Journal of animal science and biotechnology, 7, 1. https://doi.org/10.1186/s40104-015-0057-5
Reiter, J., Levina, N., van der Linden, M., Gruhlke, M., Martin, C., & Slusarenko, A. J. (2017). Diallylthiosulfinate (Allicin), a Volatile Antimicrobial from Garlic (Allium sativum), Kills Human Lung Pathogenic Bacteria, Including MDR Strains, as a Vapor. Molecules (Basel, Switzerland), 22(10), 1711. https://doi.org/10.3390/molecules22101711
Ankri, S., & Mirelman, D. (1999). Antimicrobial properties of allicin from garlic. Microbes and infection, 1(2), 125–129. https://doi.org/10.1016/s1286-4579(99)80003-3
Wu, S., Yang, K., Hong, Y., Gong, Y., Ni, J., Yang, N., & Ding, W. (2022). A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureusRevealed by Untargeted Metabolomic Studies. Frontiers in microbiology, 13, 917414. https://doi.org/10.3389/fmicb.2022.917414
Wylie MR and Merrell DS (2022) The Antimicrobial Potential of the Neem Tree Azadirachta indica. Pharmacol.13:891535. https://doi.org/10.3389/fphar.2022.891535
Lu, M., Dai, T., Murray, C. K., & Wu, M. X. (2018). Bactericidal Property of Oregano Oil Against Multidrug-Resistant Clinical Isolates. Frontiers in microbiology, 9, 2329. https://doi.org/10.3389/fmicb.2018.02329
Si, W., Gong, J., Tsao, R., Zhou, T., Yu, H., Poppe, C., Johnson, R., & Du, Z. (2006). Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. Journal of applied microbiology, 100(2), 296–305. https://doi.org/10.1111/j.1365-2672.2005.02789.x
Shrestha, L., Fan, H. M., Tao, H. R., & Huang, J. D. (2022). Recent Strategies to Combat Biofilms Using Antimicrobial Agents and Therapeutic Approaches. Pathogens (Basel, Switzerland), 11(3), 292. https://doi.org/10.3390/pathogens11030292
Omura, Y., O'Young, B., Jones, M., Pallos, A., Duvvi, H., & Shimotsuura, Y. (2011). Caprylic acid in the effective treatment of intractable medical problems of frequent urination, incontinence, chronic upper respiratory infection, root canalled tooth infection, ALS, etc., caused by asbestos & mixed infections of Candida albicans, Helicobacter pylori & cytomegalovirus with or without other microorganisms & mercury. Acupuncture & electro-therapeutics research, 36(1-2), 19–64. https://doi.org/10.3727/036012911803860886
Camaioni, L., Ustyanowski, B., Buisine, M., Lambert, D., Sendid, B., Billamboz, M., & Jawhara, S. (2023). Natural Compounds with Antifungal Properties against Candida albicansand Identification of Hinokitiol as a Promising Antifungal Drug. Antibiotics (Basel, Switzerland), 12(11), 1603. https://doi.org/10.3390/antibiotics12111603
Yoshida, S., Kasuga, S., Hayashi, N., Ushiroguchi, T., Matsuura, H., & Nakagawa, S. (1987). Antifungal activity of ajoene derived from garlic. Applied and environmental microbiology, 53(3), 615–617. https://doi.org/10.1128/aem.53.3.615-617.1987
Shariati A, Didehdar M, Razavi S, Heidary M, Soroush F and Chegini Z (2022) Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against CandidaFront. Pharmacol. 13:917787. doi: 10.3389/fphar.2022.917787
Anna Krasowska, Anna Murzyn, Agnieszka Dyjankiewicz, Marcin Łukaszewicz, Dorota Dziadkowiec, The antagonistic effect of Saccharomyces boulardiion Candida albicans filamentation, adhesion and biofilm formation, FEMS Yeast Research, Volume 9, Issue 8, December 2009, Pages 1312–1321, https://doi.org/10.1111/j.1567-1364.2009.00559.x
Sorathia SJ, Chippa V, Rivas JM. Small Intestinal Bacterial Overgrowth. [Updated 2023 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546634/
Bondaryk, M., Kurzątkowski, W., & Staniszewska, M. (2013). Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development. Postepy dermatologii i alergologii, 30(5), 293–301. https://doi.org/10.5114/pdia.2013.38358
Allonsius, C. N., van den Broek, M. F. L., De Boeck, I., Kiekens, S., Oerlemans, E. F. M., Kiekens, F., Foubert, K., Vandenheuvel, D., Cos, P., Delputte, P., & Lebeer, S. (2017). Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides. Microbial biotechnology, 10(6), 1753–1763. https://doi.org/10.1111/1751-7915.12799
Mohd Fuad, A., Wan Mazlan, W. N. A., Abdul Wahab, R., Nasruddin, N. S., & Arzmi, M. H. (2023). The effect of probiotic Lactobacillus rhamnosus GG on Candida albicans and Candida tropicalis biofilm formation: A preliminary study. IIUM Journal of Orofacial and Health Sciences, 4(2), 126–131. https://doi.org/10.31436/ijohs.v4i2.204
Salari, S., & Ghasemi Nejad Almani, P. (2020). Antifungal effects of Lactobacillus acidophilus and Lactobacillus plantarum against different oral Candida species isolated from HIV/ AIDS patients: an in vitro study. Journal of oral microbiology, 12(1), 1769386. https://doi.org/10.1080/20002297.2020.1769386
Ishikawa, K. H., Mayer, M. P., Miyazima, T. Y., Matsubara, V. H., Silva, E. G., Paula, C. R., Campos, T. T., & Nakamae, A. E. (2015). A multispecies probiotic reduces oral Candida colonization in denture wearers. Journal of prosthodontics : official journal of the American College of Prosthodontists, 24(3), 194–199. https://doi.org/10.1111/jopr.12198
García-Collinot, G., Madrigal-Santillán, E. O., Martínez-Bencomo, M. A., Carranza-Muleiro, R. A., Jara, L. J., Vera-Lastra, O., Montes-Cortes, D. H., Medina, G., & Cruz-Domínguez, M. P. (2020). Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Digestive diseases and sciences, 65(4), 1134–1143. https://doi.org/10.1007/s10620-019-05830-0
Efremova, I., Maslennikov, R., Zharkova, M., Poluektova, E., Benuni, N., Kotusov, A., Demina, T., Ivleva, A., Adzhieva, F., Krylova, T., & Ivashkin, V. (2024). Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of clinical medicine, 13(3), 919. https://doi.org/10.3390/jcm13030919
Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91

Candida Overgrowth & SIBO Explained: Symptoms, Root Causes, and Healing ROAdMAP Read More »

Probiotics for SIBO – Do they Help or Harm?

bloating, dysbiosis, gut microbiome, gut support, IBS, inflammation, microbiome, probiotic sibo healing, probiotics, SIBO, supplements, treatment

If you've been struggling with SIBO (Small Intestinal Bacterial Overgrowth), you may be familiar with the uncomfortable symptoms, such as bloating, gas, pain, and unpredictable bowel movements, which can make everyday life a challenge.

Naturally, you want relief. But when it comes to probiotics for SIBO, the advice is all over the place. Some people swear by them, while others warn that probiotics could worsen symptoms by feeding the overgrowth.

So, what's the real answer? Can probiotics help with SIBO, or should you avoid them completely?

What is SIBO, and how does it feel?

SIBO happens when bacteria that should stay in the large intestine start growing in the small intestine. Since the small intestine is designed for nutrient absorption—not fermentation—this overgrowth can cause major digestive issues. (1)

Common SIBO symptoms:

Bloating (especially after eating)
Gas and distension
Diarrhea, constipation, or both
Nutrient deficiencies (B12, iron, fat-soluble vitamins)
Abdominal pain and discomfort
Brain fog and fatigue
Muscle and joint pain
Skin issues (eczema, rosacea, acne)

SIBO is often misdiagnosed as IBS because the symptoms overlap. However, IBS treatments don't always work for SIBO because they don't address bacterial overgrowth.

The underlying reasons for SIBO can also be many things, from impaired gut motility, insufficient digestive juice production, infections, and structural problems.

What are probiotics?

Probiotics are live microorganisms—mainly beneficial bacteria and yeasts—that support gut health when consumed in the right amounts. The word "probiotic" comes from the Greek "pro bios," meaning "for life."

Unlike harmful bacteria that cause infections, probiotics help balance your gut microbiome and promote better digestion, immunity, and overall health.

Probiotics benefit the gut by:

Crowding out harmful bacteria – By competing for space and nutrients, probiotics can prevent the overgrowth of pathogenic bacteria.
Enhancing digestion – Certain strains help break down food, absorb nutrients, and even produce vitamins like B12 and K2.
Supporting gut barrier function – They strengthen the gut lining, reducing leaky gut and inflammation.
Producing beneficial compounds – Many probiotics create short-chain fatty acids (SCFAs) and antimicrobial substances that support gut health.
Regulating the immune system – A balanced microbiome prevents excessive immune reactions, helping conditions like IBS, allergies, and autoimmune disorders.
and many more benefits (2) (3) (4) (5)

Types of probiotics

Probiotics come in various strains, each with different benefits.

The most common types include:

Lactobacillus & Bifidobacterium – Found in yogurt, kefir, and supplements. They aid digestion and boost immunity.
Saccharomyces boulardii – A probiotic yeast that fights harmful bacteria and supports gut healing.
Soil-based probiotics (Bacillus species) – Hardy strains that survive stomach acid and support microbiome balance. (6)

Probiotics for SIBO – is it a yes or a no?

The biggest concern with probiotics and SIBO is that you're adding more bacteria to an overgrowth situation. Wouldn't that make things worse?

Why some experts say to avoid probiotics for SIBO:

Many probiotics contain Lactobacillus and Bifidobacterium, which may colonize the small intestine and worsen bloating.
Some strains (e.g., Lactobacillus bulgaricus, L. casei, Streptococcus thermophilus, etc.) increase histamine, triggering inflammation. (7)
Multi-strain probiotics might exacerbate symptoms instead of helping.
Certain ingredients in these products may worsen symptoms, such as prebiotics, starches, lactose, maltodextrin, etc.

Why some experts recommend probiotics for SIBO:

Certain probiotic strains produce antimicrobial compounds that fight bad bacteria. (8)
Some probiotics help improve gut motility, preventing bacterial stagnation. (9)
Probiotics may reduce inflammation, enhance gut barrier function, supporting gut healing. (10)

The best probiotic strains for SIBO

The key to using probiotics for SIBO is choosing the right strains. Research suggests that certain probiotics can reduce symptoms and even help prevent SIBO relapse.

Are there promising results that probiotics for SIBO are effective?

A pilot study compared the effectiveness of metronidazole (Flagyl) (a common antibiotic used in methanogen overgrowth) vs. a probiotic blend in 50 patients with SIBO and chronic abdominal distension.

They found that

82% of patients taking the probiotic reported symptom improvement, compared to 52% in the antibiotic group—a statistically significant difference (P = 0.036).
The probiotic contained Lactobacillus casei, Lactobacillus plantarum, Streptococcus faecalis, and Bifidobacterium brevis (Bioflora).
No major side effects were reported in either group.

This study suggests that probiotics may be more effective than metronidazole for improving SIBO-related bloating and abdominal distension in the short term. While more research is needed, probiotics could be a promising alternative or complementary approach to antibiotics in SIBO treatment. (11)

Another study investigated the effects of Bacillus clausii in patients with SIBO diagnosed via hydrogen breath test (HBT). In this study, patients were given Bacillus clausii (a spore-forming probiotic) for treatment. Results showed that Bacillus clausii normalized hydrogen breath tests at rates comparable to antibiotics. Patients also experienced symptomatic relief, particularly in bloating and gas production. (12)

Let's look at the various strains that show promising results

Lactobacillus reuteri DSM 17938

This probiotic strain has been found to have a beneficial effect on chronic constipation by massively decreasing methane production and improving gut motility. (13)
It was found to reduce abdominal pain in children. (14)
It has also been shown to prevent SIBO occurrence in patients taking proton pump inhibitors (PPIs) (a medication used to reduce stomach acid production). (15)
reuteri also has antimicrobial (produce Reuterin and other substances) properties and is effective against Helicobacter pylori, E. Coli, Clostridium difficile, and Salmonella infection. It has been suggested that L. reuteri has antiviral components and antifungal properties against Candida species and can reduce inflammation. (16)
It can produce vitamin B12 (cobalamin) and B9 (folate), which are often low in patients with SIBO. (16)

Most studies use 1 × 10⁸ to 2 × 10⁸ CFU (colony-forming units) per day. This is typically delivered in one or two doses daily.

Research suggests that taking Lactobacillus reuteri DSM 17938 for 4–8 weeks may provide benefits, especially for reducing methane production and improving gut motility in SIBO patients. (17)

An example product is BioGaia Protectis Drops (5 drops per day, which provides 1 × 10⁸ CFU of Lactobacillus reuteri DSM 17938).

Or BioGaia Gastrus that contains 200 million CFU (2 × 10⁸ CFU) per tablet of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475. Typically used for gut motility, methane overgrowth, and H. pylori support. (for more clinical studies, check out this guide created by >>Biogaia<<

Bifidobacterium lactis HN019

This strain has been found to improve gut motility and bowel movement frequency in cases of functional constipation (18)
It reduces bloating and gas by rebalancing gut bacteria (19)
It has been reported to reduce the frequency of functional gastrointestinal symptoms in adults, including abdominal pain, nausea, constipation, diarrhea, and flatulence (17)

Clinical studies have used 1 × 10⁹ to 1 × 10¹⁰ CFU (1–10 billion CFU) per day for gut motility and digestive benefits. Some studies have used up to 17.2 billion CFU per day for improving gut transit time (19)

4–8 weeks is the typical study duration for improving constipation and bloating. Some trials suggest effects may be seen as early as 14 days, but the best results occur after a month or more.

An example of products could be Life Extension, Florassist® Probiotic, Daily Bowel Regularity.

Lactobacillus plantarum 299v

Lactobacillus plantarum 299v (LP299V) is a well-researched probiotic strain, particularly for gut health, IBS, and inflammatory conditions.

Potential benefits for SIBO & gut health:

Reduces bloating and abdominal pain in IBS patients - A randomized controlled trial found that LP299V significantly reduced bloating and pain in IBS patients (20)
Strengthens gut barrier function (reduces leaky gut) - LP299V has been shown to improve intestinal permeability, helping strengthen the gut barrier in stressed individuals (21). Many SIBO patients have leaky gut, which can worsen inflammation and food intolerances.
Reduces inflammation and modulates immune response - LP299V has been shown to lower inflammatory markers like TNF-α and IL-6 in patients with IBS (22). Chronic inflammation is common in SIBO due to bacterial toxins; LP299V may help reduce this.

Most clinical studies use 5 × 10^9 to 1 × 10^10 CFU per day (up to 100 billion CFU) per day.

Research suggests taking LP299V for 4–12 weeks provides the most benefits for gut motility, inflammation, and bloating relief. (23),(24)

An example product is Jarrow Formulas, Vegan Ideal Bowel Support, 10 Billion CFU.

Saccharomyces boulardii

Saccharomyces boulardii (S. boulardii) is a unique probiotic yeast that has been widely studied for gut health, diarrhea, and microbiome restoration. Unlike bacterial probiotics (like Lactobacillus and Bifidobacterium), S. boulardii is a non-colonizing yeast, meaning it doesn't stay in the gut long-term—it works while you take it and is eliminated within a few days after stopping supplementation.

This makes S. boulardii particularly useful in SIBO treatment, as it does not contribute to bacterial overgrowth but still provides key gut-supportive benefits. (25)

Supports SIBO antibiotic therapy without being destroyed - unlike bacterial probiotics, boulardii is not affected by antibiotics, making it an excellent choice during or after SIBO antibiotic treatment. A clinical trial showed that adding S. boulardii to antibiotic treatment like metronidazole improved SIBO eradication rates compared to antibiotics alone. (26)
In another study, in patients with decompensated cirrhosis, a 3-month course of S. boulardii eliminated SIBO in 80% of cases, compared to 23.1% in a placebo group. (27)
Reduces digestive symptoms - S. boulardii has been shown to reduce diarrhea and antibiotic-associated diarrhea significantly. (28) Hydrogen-dominant SIBO is often associated with chronic diarrhea, and S. boulardii can help regulate stool consistency.
Clinical trials show that adding S. boulardii to antibiotic therapy can improve SIBO-related diarrhea and abdominal pain faster than antibiotics alone (29).
A meta-analysis found another type of yeast, Saccharomyces cerevisiae (S. Cerevisiae CNCM I-3856), to significantly improve abdominal pain and discomfort, bloating, as well as stool consistency in IBS patients. (30)
Modulates the immune system & reduces gut inflammation – S. boulardii was shown to reduce pro-inflammatory cytokines (IL-6, TNF-α) and improve gut immune function. (31) Why does this matter for SIBO? Because SIBO triggers gut inflammation, leading to bloating, food sensitivities, and leaky gut. S. boulardii helps calm the immune response and protect the gut lining.
Supports gut microbiome balance - One of the biggest challenges in SIBO treatment is that antibiotics can kill both harmful and beneficial bacteria, leading to gut dysbiosis and a higher risk of relapse. Since S. boulardii is a yeast and not a bacterium, it is resistant to antibiotics and can help restore gut balance during and after antibiotic treatment. A randomized trial found that boulardii protected the gut microbiome from antibiotic-induced dysbiosis in healthy volunteers (32). A clinical study on patients with SIBO and IBS-D found that S. boulardii supplementation reduced harmful bacteria (Proteobacteria) and increased beneficial anti-inflammatory microbes (F. prausnitzii) (29)

How Saccharomyces boulardii is different from bacterial probiotics

Saccharomyces boulardii vs bacterial probiotics

Key takeaway: S. boulardii is ideal for SIBO patients undergoing antibiotic treatment or those who want symptom relief without increasing bacterial overgrowth.

The general recommended dosage:

Standard dose: 250–500 mg per day (equivalent to 5–10 billion CFU per day).
Higher doses (up to 1,000 mg per day) have been used in some studies for diarrhea and gut inflammation.

Duration:

During antibiotic therapy: Take S. boulardii alongside antibiotics to prevent dysbiosis and increase the rate of eradication of SIBO.
Post-SIBO treatment: Continue for 4–8 weeks to support microbiome recovery.
For chronic SIBO symptoms: May be taken long-term as needed.

An example product containing Saccharomyces boulardii is Florastor (by Biocodex), which is one of the most well-studied S. boulardii brands.

Soil-based probiotics (Bacillus strains)

Soil-based probiotics (SBOs) are spore-forming bacteria that naturally exist in the environment. Unlike traditional Lactobacillus and Bifidobacterium probiotics, SBOs are highly resilient, surviving stomach acid, antibiotics, and harsh gut conditions.

This makes SBOs particularly useful for SIBO, as they:

Do not contribute to bacterial overgrowth in the small intestine.
Resist destruction by antibiotics, so they can be used during and after SIBO treatment.
Produce antimicrobial compounds, which may help control SIBO-related bacteria.

There are a lot of types of soil-based bacteria, but the most common species are:

Bacillus Clausii
Bacillus Coagulans
Bacillus Subtilis
Bacillus indicus
Bacillus licheniformis

I want to clarify the benefits of using some of the safest and most effective species for gut health based on research, including Bacillus Clausii, Bacillus Coagulans, and Bacillus Subtilis.

Benefits of Soil-based probiotics for gut health

Bacillus clausii

Bacillus clausii is a spore-forming bacterium that is heat and shelf-stable.

Here are some of its benefits for gut health:

Helps reduce diarrhea - Evidence from clinical studies suggests that B. clausii shows effectiveness in preventing and treating diarrhea in adults and children, including diarrhea resulting from antibiotic treatment. (33)
Survives antibiotics & prevents dysbiosis (gut imbalance)- A clinical trial found that Bacillus clausii restored microbiome balance in patients taking antibiotics (34). Why it matters? Since SIBO is often treated with antibiotics, taking B. clausii during and after treatment may reduce side effects and prevent relapse.
Reduces IBS symptoms, boosts the immune system & reduces inflammation - B. clausii was shown to modulate the immune response and reduce gut inflammation in patients with IBS. They significantly reduced abdominal pain in children with IBS. (35) Many SIBO patients suffer from gut inflammation and immune dysfunction, making B. clausii a valuable strain for gut healing.
Helpful in SIBO eradication – a study involving 40 patients diagnosed with SIBO found that after taking Enterogermina for one month, 47% of participants showed a normalized glucose breath test result. (36)

General dosage & duration:

5–10 billion CFU per day
Duration: 4–8 weeks, especially during & after antibiotic therapy

Example Product: Enterogermina (Sanofi) – One of the most well-studied B. clausii probiotics, commonly used with antibiotics.

Bacillus coagulans

It is the most studied soil-based probiotic. There have been quite a few studies on its effectiveness for IBS.

Key benefits for gut health:

Reduces digestive symptoms:
- B. coagulans (MTCC 5856) was shown to have a positive effect on diarrhea in IBS patients. (37)
- B. coagulans (GBI-30, 6086) was shown to relieve abdominal pain and bloating (38).
- A clinical trial showed that Bacillus coagulans (SNZ 1969) increased gut motility and reduced constipation. (39)
A study suggests that GanedenBC30 (Bacillus coagulans) may aid in the digestion of lactose, fructose, and milk protein, potentially reducing intestinal symptoms in individuals sensitive to these carbohydrates. However, its effectiveness could be greater if more spores germinated. (40)
Effective for SIBO:
- In a clinical trial involving 30 individuals with chronic abdominal pain or diarrhea and a positive hydrogen breath test (HBT) for SIBO, B. coagulans Unique IS-2 was found to be effective. After three weeks of antibiotic therapy, participants were given either B. coagulans Unique IS-2 or a placebo for 15 days alongside maintenance antibiotics. After six months, the probiotic group showed significant improvements:
  - Gastrointestinal symptoms like belching, flatulence, and diarrhea significantly improved.
  - Abdominal pain disappeared completely.
  - 93% of individuals in the probiotic group had negative hydrogen breath tests, compared to 67% in the placebo group. (41)

General dosage & duration:

2–10 billion CFU per day
Duration: 6–8 weeks for symptom relief, but can be used long-term for gut support.

Example product: LactoSpore® (B. coagulans MTCC 5856)

Bacillus subtilis

Key benefits for gut health:

Improves gut motility – a study showed that B. Subtilis (DE111) improves occasional constipation and/or diarrhea in healthy individuals. (42)
Reduces gut symptoms – In another study, Bacillus subtilis MB40 (MB40) was shown to reduce bloating intensity, abdominal discomfort, and gas in healthy participants. (43)
Reduces abdominal pain – a study found that Medilac DS (Bacillus subtilis with Streptococcus faecium) is a safe and useful probiotic agent for the treatment of abdominal pain in patients with IBS. (44)
Helps in H. Pylori eradication - Supplementation with probiotic strains, composed of Bacillus subtilis and Streptococcus faecium, were shown to improve drug compliance, reduce side effects, and enhance the intention-to-treat eradication rate of Helicobacter pylori. (45)

General dosage & duration:

1–4 billion CFU per day
Duration: 8–12 weeks for biofilm disruption

Example product: CoreBiotic (Researched Nutritionals) – Contains Bacillus subtilis along with other SBOs.

Are soil-based probiotics safe for SIBO?

There is some concern that certain soil-based probiotics (SBOs) may persist too long in the gut or pose risks for immunocompromised individuals.

However, well-researched strains like Bacillus clausii, Bacillus coagulans, and Bacillus subtilis have shown strong safety profiles and gut health benefits, particularly for reducing inflammation, supporting digestion, and balancing the gut microbiome.

While most studies focus on IBS rather than SIBO, the overlapping symptoms (bloating, diarrhea, constipation, abdominal pain) suggest that SBOs could offer similar benefits, particularly for bloating, motility issues, and microbiome repair after antibiotic therapy. Choosing clinically studied strains and monitoring tolerance is key to safely incorporating SBOs into a SIBO recovery plan.

If you don't want to experiment with soil-based probiotic supplements, you can expose yourself to them in a natural way through gardening, touching dirt, growing organic vegetables, and spending time outdoors.

How to take probiotics for SIBO without making symptoms worse

While probiotics can be incredibly beneficial for gut healing and microbiome balance, choosing the wrong product (especially multi-strain products) or introducing it too quickly may worsen bloating, gas, or discomfort. Plus, you may need to be extra careful if you suffer from histamine issues or have other immune system-related health challenges.

Here's how to safely incorporate probiotics into your SIBO treatment plan:

Start slow and low – Introduce one strain at a time and monitor symptoms. Gradually increase over 1–2 weeks, based on tolerance.
Choose products that clearly list the strains. - Each strain should be identified on the label. For example, not just Bacillus coagulans, but Bacillus coagulans MTCC 5856.
CFU count should be visible on the label – The label should specify billions of CFUs per dose.
Includes an expiration or manufacturing date – This ensures the bacteria remain viable.
Check the ingredient list – The product should be free from common allergens like gluten and dairy, and ideally, you want to have a product without added prebiotics (like inulin) if you have SIBO.
Manufactured under Good Manufacturing Practices (GMP) – This ensures safety and quality control.
Third-party tested – Independent lab verification confirms strain accuracy and potency.
Pair with other SIBO treatments – Probiotics alone won't cure SIBO. Use them alongside dietary and lifestyle changes, treatment, addressing the root causes, and prokinetics. It should be part of a holistic approach to SIBO.

Conclusion: should you use probiotics for SIBO?

The debate over probiotics for SIBO stems from concerns that adding more microbes to an already imbalanced small intestine could worsen symptoms. However, the research suggests otherwise—when the right probiotic strains are chosen, they can enhance treatment success, support microbiome recovery, and reduce relapse risk.

Certain probiotics, such as Saccharomyces boulardii and Bacillus clausii, are safe to use during antibiotic or herbal treatments, helping to prevent gut dysbiosis.

After treatment, soil-based probiotics (SBOs) like Bacillus coagulans and Bacillus subtilis can help restore microbial balance, improve motility, and strengthen the gut lining, reducing the likelihood of SIBO returning.

While most studies have focused on IBS rather than SIBO specifically, the overlap in symptoms suggests that probiotics can offer similar benefits in regulating bloating, stool consistency, and gut function. The key is to use well-researched strains, introduce them gradually, and listen to your body's response.

Verdict: Yes, probiotics can be a valuable tool for SIBO treatment and recovery—but only when carefully selected and strategically used.

This post is only for informational purposes and is not meant to diagnose, treat, or cure any disease. I recommend always consulting your healthcare practitioner before trying any treatment or dietary changes

References

References:

Achufusi, T. G. O., Sharma, A., Zamora, E. A., & Manocha, D. (2020). Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus, 12(6), e8860. https://doi.org/10.7759/cureus.8860
Hill, C., Guarner, F., Reid, G. et al.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514 (2014). https://doi.org/10.1038/nrgastro.2014.66
Bodke, H., & Jogdand, S. (2022). Role of Probiotics in Human Health. Cureus, 14(11), e31313. https://doi.org/10.7759/cureus.31313
Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N., & Fakiri, E. M. (2013). Health benefits of probiotics: a review. ISRN nutrition, 2013, 481651. https://doi.org/10.5402/2013/481651
Gul, S., & Durante-Mangoni, E. (2024). Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review. Journal of Clinical Medicine, 13(5), 1436. https://doi.org/10.3390/jcm13051436
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015). Probiotics, prebiotics and synbiotics- a review. Journal of food science and technology, 52(12), 7577–7587. https://doi.org/10.1007/s13197-015-1921-1
https://activatedprobiotics.com.au/wp-content/uploads/2024/06/AP_Histamine-Gene-Table_A4_DX.pdf
Fijan S. (2023). Probiotics and Their Antimicrobial Effect. Microorganisms, 11(2), 528. https://doi.org/10.3390/microorganisms11020528
Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr. 2017 May 15;8(3):484-494. doi: 10.3945/an.116.014407. PMID: 28507013; PMCID: PMC5421123.
Chen, W. C., & Quigley, E. M. (2014). Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!. The Indian journal of medical research, 140(5), 582–584.I https://pmc.ncbi.nlm.nih.gov/articles/PMC4311309/
Soifer, L. O., Peralta, D., Dima, G., & Besasso, H. (2010). Eficacia comparativa de un probiótico vs un antibiótico en la respuesta clínica de pacientes con sobrecrecimiento bacteriano del intestino y distensión abdominal crónica funcional: un estudio piloto [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study]. Acta gastroenterologica Latinoamericana, 40(4), 323–327. I https://pubmed.ncbi.nlm.nih.gov/21381407/
Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
Ojetti, V., Petruzziello, C., Migneco, A., Gnarra, M., Gasbarrini, A., & Franceschi, F. (2017). Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. European review for medical and pharmacological sciences, 21(7), 1702–1708.
Weizman, Z., Abu-Abed, J., & Binsztok, M. (2016). Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of pediatrics, 174, 160–164.e1. https://doi.org/10.1016/j.jpeds.2016.04.003
Belei, O., Olariu, L., Dobrescu, A., Marcovici, T., & Marginean, O. (2018). Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?. Journal of neurogastroenterology and motility, 24(1), 51–57. https://doi.org/10.5056/jnm17059
Mu, Q., Tavella, V. J., & Luo, X. M. (2018). Role of Lactobacillus reuteriin Human Health and Diseases. Frontiers in microbiology, 9, 757. https://doi.org/10.3389/fmicb.2018.00757
Ojetti, V., Petruzziello, C., Migneco, A., Gnarra, M., Gasbarrini, A., & Franceschi, F. (2017). Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. European review for medical and pharmacological sciences, 21(7), 1702–1708.
Cheng, J., Laitila, A., & Ouwehand, A. C. (2021). Bifidobacterium animalislactis HN019 Effects on Gut Health: A Review. Frontiers in nutrition, 8, 790561. https://doi.org/10.3389/fnut.2021.790561
Waller, P. A., Gopal, P. K., Leyer, G. J., Ouwehand, A. C., Reifer, C., Stewart, M. E., & Miller, L. E. (2011). Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scandinavian journal of gastroenterology, 46(9), 1057–1064. https://doi.org/10.3109/00365521.2011.584895
Ducrotté, P., Sawant, P., & Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World journal of gastroenterology, 18(30), 4012–4018. https://doi.org/10.3748/wjg.v18.i30.4012
Kaźmierczak-Siedlecka, K., Daca, A., Folwarski, M., Witkowski, J. M., Bryl, E., & Makarewicz, W. (2020). The role of Lactobacillus plantarum299v in supporting treatment of selected diseases. Central-European journal of immunology, 45(4), 488–493. https://doi.org/10.5114/ceji.2020.101515
Malik, M., Suboc, T. M., Tyagi, S., Salzman, N., Wang, J., Ying, R., Tanner, M. J., Kakarla, M., Baker, J. E., & Widlansky, M. E. (2018). Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease. Circulation research, 123(9), 1091–1102. https://doi.org/10.1161/CIRCRESAHA.118.313565
Stevenson, C., Blaauw, R., Fredericks, E., Visser, J., & Roux, S. (2014). Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition (Burbank, Los Angeles County, Calif.), 30(10), 1151–1157. https://doi.org/10.1016/j.nut.2014.02.010
Krammer, H., Storr, M., Madisch, A., & Riffel, J. (2021). Reizdarmbehandlung mit Lactobacillus plantarum 299v: Längere Einnahme verstärkt Behandlungserfolg – Ergebnisse einer nichtinterventionellen Studie [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. Zeitschrift fur Gastroenterologie, 59(2), 125–134. https://doi.org/10.1055/a-1340-0204
Pais, P., Almeida, V., Yılmaz, M., & Teixeira, M. C. (2020). Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. Journal of fungi (Basel, Switzerland), 6(2), 78. https://doi.org/10.3390/jof6020078
García-Collinot, G., Madrigal-Santillán, E. O., Martínez-Bencomo, M. A., Carranza-Muleiro, R. A., Jara, L. J., Vera-Lastra, O., Montes-Cortes, D. H., Medina, G., & Cruz-Domínguez, M. P. (2020). Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Digestive diseases and sciences, 65(4), 1134–1143. https://doi.org/10.1007/s10620-019-05830-0
Efremova, I., Maslennikov, R., Zharkova, M., Poluektova, E., Benuni, N., Kotusov, A., Demina, T., Ivleva, A., Adzhieva, F., Krylova, T., & Ivashkin, V. (2024). Efficacy and Safety of a Probiotic Containing Saccharomyces boulardiiCNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of clinical medicine, 13(3), 919. https://doi.org/10.3390/jcm13030919
Billoo, A. G., Memon, M. A., Khaskheli, S. A., Murtaza, G., Iqbal, K., Saeed Shekhani, M., & Siddiqi, A. Q. (2006). Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World journal of gastroenterology, 12(28), 4557–4560. https://doi.org/10.3748/wjg.v12.i28.4557
Bustos Fernández, L. M., Man, F., & Lasa, J. S. (2023). Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study. Digestive diseases (Basel, Switzerland), 41(5), 798–809. https://doi.org/10.1159/000528954
Cayzeele-Decherf, A., Pélerin, F., Leuillet, S., Douillard, B., Housez, B., Cazaubiel, M., Jacobson, G. K., Jüsten, P., & Desreumaux, P. (2017). Saccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World journal of gastroenterology, 23(2), 336–344. https://doi.org/10.3748/wjg.v23.i2.336
Stier, H., & Bischoff, S. C. (2016). Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system. Clinical and experimental gastroenterology, 9, 269–279. https://doi.org/10.2147/CEG.S111003
Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-Galvez, J., Vanga, R. R., Castillo, N. E., Hansen, J., Dennis, M., Leffler, D. A., & Kelly, C. P. (2017). Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut microbes, 8(1), 17–32. https://doi.org/10.1080/19490976.2016.1267890
Acosta-Rodríguez-Bueno, C. P., Abreu Y Abreu, A. T., Guarner, F., Guno, M. J. V., Pehlivanoğlu, E., & Perez, M., 3rd (2022). Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Advances in therapy, 39(11), 4854–4874. https://doi.org/10.1007/s12325-022-02285-0
Maity, C., & Gupta, A. K. (2021). Therapeutic efficacy of probiotic Alkalihalobacillus clausii088AE in antibiotic-associated diarrhea: A randomized controlled trial. Heliyon, 7(9), e07993. https://doi.org/10.1016/j.heliyon.2021.e07993
Vázquez-Frias, R., Consuelo-Sánchez, A., Acosta-Rodríguez-Bueno, C. P., Blanco-Montero, A., Robles, D. C., Cohen, V., Márquez, D., & Perez, M., 3rd (2023). Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Paediatric drugs, 25(1), 115–126. https://doi.org/10.1007/s40272-022-00536-9
Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
Majeed, M., Nagabhushanam, K., Natarajan, S., Sivakumar, A., Ali, F., Pande, A., Majeed, S., & Karri, S. K. (2016). Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutrition journal, 15, 21. https://doi.org/10.1186/s12937-016-0140-6
Hun L. (2009). Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgraduate medicine, 121(2), 119–124. https://doi.org/10.3810/pgm.2009.03.1984
Kang, S., Park, M. Y., Brooks, I., Lee, J., Kim, S. H., Kim, J. Y., Oh, B., Kim, J. W., & Kwon, O. (2021). Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: A randomized controlled trial. Food research international (Ottawa, Ont.), 146, 110428. https://doi.org/10.1016/j.foodres.2021.110428
Maathuis, A. J., Keller, D., & Farmer, S. (2010). Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. Beneficial microbes, 1(1), 31–36. https://doi.org/10.3920/BM2009.0009
Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
Cuentas, A. M., Deaton, J., Davidson, J., Ardita, C. & Khan, S. The Effect of Bacillus subtilis DE111 on the Daily Bowel Movement Profile for People with Occasional Gastrointestinal Irregularity. Journal of Probiotics & Health 5, 1–4 (2017).
Penet, C., Kramer, R., Little, R., Spears, J. L., Parker, J., Iyer, J. K., Guthrie, N., & Evans, M. (2021). A Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating. Alternative therapies in health and medicine, 27(S1), 146–157.
Kim, Y. G., Moon, J. T., Lee, K. M., Chon, N. R., & Park, H. (2006). The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 47(6), 413–419.
Park, S. K., Park, D. I., Choi, J. S., Kang, M. S., Park, J. H., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2007). The effect of probiotics on Helicobacter pylori eradication. Hepato-gastroenterology, 54(79), 2032–2036.

Probiotics for SIBO – Do they Help or Harm? Read More »